Unpacking the 2026 CKM Syndrome Guideline

Webinar Overview

Join ACC's Prevention of Cardiovascular Disease Member Section for a deep dive into the 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome Guideline and how it relates to your clinical practice.

The newly released cardiovascular-kidney-metabolic syndrome (CKM) Guideline offers important, comprehensive recommendations and practice-relevant insights. To help reduce long-term cardiovascular and kidney complications, the Guideline introduces a structured CKM staging framework, highlights the use of PREVENT risk equations for more accurate assessment and emphasizes the importance of coordinated, interdisciplinary care. This webinar, hosted by the ACC's Prevention of Cardiovascular Disease Member Section, will review key highlights from the Guideline and explore its implications for clinical practice. Guideline authors and clinical experts will deliver a concise overview followed by an interactive discussion and audience Q&A.

Key Objectives/Learning Outcomes:

  1. Review the key differences from the 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults, which this Guideline replaces and expands upon.
  2. Review the Guideline's structured CKM staging framework and how it can be used in your clinical practice.
  3. Gain familiarity with PREVENT risk equations and interdisciplinary care strategies designed to reduce long-term cardiovascular and kidney complications.

Webinar Participants

Nishant Shah, MD, FACC
Katie Benziger, MD, MPH, FACC
Chiadi E. Ndumele, MD, PhD
Fatima Rodriguez, MD, MPH, FACC
Dave L. Dixon, PharmD, FACC
Anum Saeed, MD

Credit Information

No credit is being offered for this webinar.

Clinical Topics: Prevention

Keywords: